002826 易明医药
已收盘 01-23 15:00:00
资讯
新帖
简况
易明医药(002826)1月20日股东户数1.84万户,较上期减少1.48%
中金财经 · 01-22
易明医药(002826)1月20日股东户数1.84万户,较上期减少1.48%
易明医药:截至2026年1月9日股东数为18,668户
证券之星 · 01-14
易明医药:截至2026年1月9日股东数为18,668户
股市必读:易明医药(002826)股东户数1.81万户,较上期增加0.25%
证券之星 · 01-07
股市必读:易明医药(002826)股东户数1.81万户,较上期增加0.25%
易明医药:截至2025年12月31日股东数为18,111户
证券之星 · 01-06
易明医药:截至2025年12月31日股东数为18,111户
股市必读:12月31日易明医药现3035.76万元大宗交易
证券之星 · 01-05
股市必读:12月31日易明医药现3035.76万元大宗交易
每周股票复盘:12月31日易明医药(002826)现3035.76万元大宗交易
证券之星 · 01-03
每周股票复盘:12月31日易明医药(002826)现3035.76万元大宗交易
12月31日易明医药现3035.76万元大宗交易
证券之星 · 2025-12-31
12月31日易明医药现3035.76万元大宗交易
股市必读:易明医药(002826)股东户数1.81万户,较上期减少2.34%
证券之星 · 2025-12-25
股市必读:易明医药(002826)股东户数1.81万户,较上期减少2.34%
易明医药:截至2025年12月19日股东数为18,066户
证券之星 · 2025-12-24
易明医药:截至2025年12月19日股东数为18,066户
易明医药:截至2025年12月10日股东数为18,499户
证券之星 · 2025-12-12
易明医药:截至2025年12月10日股东数为18,499户
易明医药:截至2025年11月28日股东数为18,604户
证券之星 · 2025-12-01
易明医药:截至2025年11月28日股东数为18,604户
易明医药(002826)11月20日股东户数1.89万户,较上期减少10.51%
证券之星 · 2025-11-24
易明医药(002826)11月20日股东户数1.89万户,较上期减少10.51%
易明医药:公司目前没有收购58同城或转转相关资产的计划
证券之星 · 2025-11-21
易明医药:公司目前没有收购58同城或转转相关资产的计划
股市必读:易明医药(002826)股东户数2.11万户,较上期增加6.1%
中金财经 · 2025-11-06
股市必读:易明医药(002826)股东户数2.11万户,较上期增加6.1%
易明医药:截至2025年10月31日股东数为21,147户
证券之星 · 2025-11-05
易明医药:截至2025年10月31日股东数为21,147户
易明医药(002826)2025年三季报简析:净利润同比增长95.52%,盈利能力上升
证券之星 · 2025-10-30
易明医药(002826)2025年三季报简析:净利润同比增长95.52%,盈利能力上升
易明医药(002826)10月20日股东户数1.99万户,较上期增加3.6%
证券之星 · 2025-10-28
易明医药(002826)10月20日股东户数1.99万户,较上期增加3.6%
易明医药(002826.SZ)发布前三季度业绩,归母净利润8176.33万元,增长95.52%
智通财经 · 2025-10-28
易明医药(002826.SZ)发布前三季度业绩,归母净利润8176.33万元,增长95.52%
易明医药:截至2025年10月20日股东数为19,931户
证券之星 · 2025-10-27
易明医药:截至2025年10月20日股东数为19,931户
股市必读:易明医药(002826)股东户数1.94万户,较上期减少8.58%
证券之星 · 2025-10-13
股市必读:易明医药(002826)股东户数1.94万户,较上期减少8.58%
加载更多
公司概况
公司名称:
西藏易明西雅医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2016-12-09
主营业务:
西藏易明西雅医药科技股份有限公司的主营业务是糖尿病、心血管疾病等老年慢性病症治疗及妇科领域核心产品的开发和研究。公司的主要产品是米格列醇片、醋氯芬酸肠溶片、蒙脱石散、红金消结片、多潘立酮片、阿奇霉素胶囊、氯雷他定片、注射用多种维生素(12)、多种微量元素注射液。截至报告期末,公司拥有发明专利28件,实用新型专利22件,药品注册批件32件,注册商标83件。
发行价格:
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":19.02,"timestamp":1769151816000,"preClose":19.51,"halted":0,"volume":7151600,"delay":0,"changeRate":-0.0251,"floatShares":174000000,"shares":191000000,"eps":0.4504,"marketStatus":"已收盘","change":-0.49,"latestTime":"01-23 15:00:00","open":19.49,"high":19.6,"low":18.85,"amount":136000000,"amplitude":0.0384,"askPrice":19.03,"askSize":108,"bidPrice":19.02,"bidSize":23,"shortable":0,"etf":0,"ttmEps":0.4504,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769391000000},"marketStatusCode":5,"adr":0,"adjPreClose":19.51,"symbolType":"stock","openAndCloseTimeList":[[1769131800000,1769139000000],[1769144400000,1769151600000]],"highLimit":21.46,"lowLimit":17.56,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.64,"roa":"--","peRate":42.22913,"roe":"10.54%","epsLYR":0.25,"committee":0.411932,"marketValue":3627000000,"turnoverRate":0.041,"status":1,"floatMarketCap":3316000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2605446418","title":"易明医药(002826)1月20日股东户数1.84万户,较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605446418","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605446418?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:42","pubTimestamp":1769074947,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2026年1月20日公司股东户数为1.84万户,较1月9日减少276.0户,减幅为1.48%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至1月20日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月9日至2026年1月20日,易明医药区间涨幅为5.05%,在此期间股东户数减少276.0户,减幅为1.48%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260122/31964287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0056","BK0239","BK0033","002826"],"gpt_icon":0},{"id":"2603548666","title":"易明医药:截至2026年1月9日股东数为18,668户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603548666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603548666?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:51","pubTimestamp":1768351865,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至1月10日的股东人数是多少?易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司最新下发的股东名册,截至2026年1月9日,本公司股东数为18,668户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400006687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","002826"],"gpt_icon":0},{"id":"2601481810","title":"股市必读:易明医药(002826)股东户数1.81万户,较上期增加0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601481810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601481810?lang=zh_cn&edition=full","pubTime":"2026-01-07 04:03","pubTimestamp":1767729795,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,易明医药报收于18.42元,下跌0.05%,换手率2.02%,成交量3.52万手,成交额6524.05万元。交易信息汇总资金流向1月6日主力资金净流出182.16万元;游资资金净流入369.74万元;散户资金净流出187.58万元。股本股东变化股东户数变动近日易明医药披露,截至2025年12月31日公司股东户数为1.81万户,较12月19日增加45.0户,增幅为0.25%。户均持股数量由上期的1.06万股减少至1.05万股,户均持股市值为19.35万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"gpt_icon":0},{"id":"2601593558","title":"易明医药:截至2025年12月31日股东数为18,111户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601593558","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601593558?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:45","pubTimestamp":1767660310,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月31日的股东人数是多少?谢谢易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年12月31日,本公司股东数为18,111户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600006937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2601886024","title":"股市必读:12月31日易明医药现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886024","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601886024?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:10","pubTimestamp":1767557422,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,易明医药报收于18.38元,上涨1.72%,换手率2.78%,成交量4.84万手,成交额8905.91万元。当日关注点来自交易信息汇总:12月31日主力资金净流入583.16万元,占总成交额6.55%。来自交易信息汇总:当日易明医药发生3035.76万元大宗交易。大宗交易12月31日易明医药现3035.76万元大宗交易。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"gpt_icon":0},{"id":"2600706086","title":"每周股票复盘:12月31日易明医药(002826)现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2600706086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600706086?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:18","pubTimestamp":1767381536,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘,易明医药(002826)报收于18.38元,较上周的18.05元上涨1.83%。本周,易明医药12月31日盘中最高价报18.77元。12月29日盘中最低价报17.81元。易明医药当前最新总市值35.05亿元,在化学制药板块市值排名124/150,在两市A股市值排名4243/5181。本周关注点交易信息汇总:12月31日易明医药现3035.76万元大宗交易交易信息汇总12月31日易明医药现3035.76万元大宗交易以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","002826","BK0239"],"gpt_icon":0},{"id":"2595842720","title":"12月31日易明医药现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2595842720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595842720?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:33","pubTimestamp":1767173602,"startTime":"0","endTime":"0","summary":"证券之星消息,12月31日易明医药发生大宗交易,交易数据如下:近三个月该股共发生2笔大宗交易,合计成交1.68万手,折价成交2笔。该股近期无解禁股上市。截至2025年12月31日收盘,易明医药(002826)报收于18.38元,上涨1.72%,换手率2.78%,成交量4.84万手,成交额8905.91万元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100031399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0033","BK0239"],"gpt_icon":0},{"id":"2594409943","title":"股市必读:易明医药(002826)股东户数1.81万户,较上期减少2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409943","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409943?lang=zh_cn&edition=full","pubTime":"2025-12-25 02:40","pubTimestamp":1766601621,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘,易明医药报收于18.03元,下跌0.17%,换手率1.13%,成交量1.97万手,成交额3564.02万元。交易信息汇总资金流向12月24日主力资金净流出635.79万元;游资资金净流入428.67万元;散户资金净流入207.12万元。股本股东变化股东户数变动截至2025年12月19日,易明医药股东户数为1.81万户,较12月10日减少433户,降幅2.34%;户均持股数量升至1.06万股,户均持股市值为19.28万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500001313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2593444031","title":"易明医药:截至2025年12月19日股东数为18,066户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444031?lang=zh_cn&edition=full","pubTime":"2025-12-24 08:54","pubTimestamp":1766537655,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月20日的股东人数是多少?谢谢易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司最新下发的股东名册,截至2025年12月19日,本公司股东数为18,066户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400006299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0},{"id":"2590217155","title":"易明医药:截至2025年12月10日股东数为18,499户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590217155","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590217155?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:36","pubTimestamp":1765510586,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2025年12月10日公司股东人数多少?易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年12月10日,本公司股东数为18,499户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200013663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0},{"id":"2588474387","title":"易明医药:截至2025年11月28日股东数为18,604户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588474387","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588474387?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576729,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至11月28日收盘公司的股东人数是多少?谢谢易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年11月28日,本公司股东数为18,604户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0033","BK0239"],"gpt_icon":0},{"id":"2585446839","title":"易明医药(002826)11月20日股东户数1.89万户,较上期减少10.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446839","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585446839?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:48","pubTimestamp":1763977694,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2025年11月20日公司股东户数为1.89万户,较10月31日减少2223.0户,减幅为10.51%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至11月20日,化学制药行业平均股东户数为3.44万户。从股价来看,2025年10月31日至2025年11月20日,易明医药区间跌幅为4.77%,在此期间股东户数减少2223.0户,减幅为10.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0056","BK0239","002826"],"gpt_icon":0},{"id":"2585311872","title":"易明医药:公司目前没有收购58同城或转转相关资产的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2585311872","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585311872?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:25","pubTimestamp":1763713542,"startTime":"0","endTime":"0","summary":"公司目前没有通过增发收购、协议收购或增发募资方式收购58同城或者转转等相关资产的计划;上市公司股价受宏观经济、市场环境变化等多种因素影响,敬请投资者理性投资,注意投资风险;公司在秉持平稳、安全运营的前提下,集中资源大力发展现有业务,促进公司稳健发展;公司设有董事会办公室负责投资者关系管理和合规事务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826"],"gpt_icon":0},{"id":"2581819410","title":"股市必读:易明医药(002826)股东户数2.11万户,较上期增加6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581819410","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581819410?lang=zh_cn&edition=full","pubTime":"2025-11-06 08:06","pubTimestamp":1762387617,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年11月5日收盘,易明医药报收于20.22元,下跌0.15%,换手率1.91%,成交量3.32万手,成交额6698.95万元。来自:截至2025年10月31日股东户数环比增长6.1%,户均持股数量下降至9017.0股,表明筹码趋于分散。资金流向11月5日主力资金净流出663.23万元;游资资金净流入336.13万元;散户资金净流入327.1万元。股东户数变动近日易明医药披露,截至2025年10月31日公司股东户数为2.11万户,较10月20日增加1216.0户,增幅为6.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251106/31771328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002826","BK0056","BK0239","BK0033"],"gpt_icon":0},{"id":"2581792872","title":"易明医药:截至2025年10月31日股东数为21,147户","url":"https://stock-news.laohu8.com/highlight/detail?id=2581792872","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581792872?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:01","pubTimestamp":1762304485,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!请问截止10月31日公司的股东人数是多少?谢谢易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年10月31日,本公司股东数为21,147户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500005847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0},{"id":"2579130026","title":"易明医药(002826)2025年三季报简析:净利润同比增长95.52%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579130026","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579130026?lang=zh_cn&edition=full","pubTime":"2025-10-30 06:30","pubTimestamp":1761777007,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期易明医药发布2025年三季报。截至本报告期末,公司营业总收入4.89亿元,同比下降4.65%,归母净利润8176.33万元,同比上升95.52%。按单季度数据看,第三季度营业总收入1.78亿元,同比上升10.37%,第三季度归母净利润4420.61万元,同比上升1934.12%。本报告期易明医药盈利能力上升,毛利率同比增幅22.52%,净利率同比增幅101.2%。去年的净利率为7.28%,算上全部成本后,公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000005775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826"],"gpt_icon":0},{"id":"2578939954","title":"易明医药(002826)10月20日股东户数1.99万户,较上期增加3.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939954?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:36","pubTimestamp":1761644163,"startTime":"0","endTime":"0","summary":"证券之星消息,近日易明医药披露,截至2025年10月20日公司股东户数为1.99万户,较10月10日增加693.0户,增幅为3.6%。在化学制药行业个股中,易明医药股东户数低于行业平均水平,截至10月20日,化学制药行业平均股东户数为3.38万户。从股价来看,2025年10月10日至2025年10月20日,易明医药区间跌幅为1.46%,在此期间股东户数增加693.0户,增幅为3.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","002826","BK0033"],"gpt_icon":0},{"id":"2578980878","title":"易明医药(002826.SZ)发布前三季度业绩,归母净利润8176.33万元,增长95.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578980878","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578980878?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:01","pubTimestamp":1761638483,"startTime":"0","endTime":"0","summary":"智通财经APP讯,易明医药(002826.SZ)发布2025年三季度报告,该公司前三季度营业收入为4.89亿元,同比减少4.65%。归属于上市公司股东的净利润为8176.33万元,同比增长95.52%。归属于上市公司股东的扣除非经常性损益的净利润为3994.73万元,同比增长144.50%。基本每股收益为0.44元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"易明医药(002826.SZ)发布前三季度业绩,归母净利润8176.33万元,增长95.52%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2578369052","title":"易明医药:截至2025年10月20日股东数为19,931户","url":"https://stock-news.laohu8.com/highlight/detail?id=2578369052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578369052?lang=zh_cn&edition=full","pubTime":"2025-10-27 15:42","pubTimestamp":1761550933,"startTime":"0","endTime":"0","summary":"证券之星消息,易明医药(002826)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止至2025年10月20日收盘公司股东人数为多少,谢谢!易明医药回复:尊敬的投资者,您好。根据中登结算深圳分公司下发的股东名册,截至2025年10月20日,本公司股东数为19,931户。感谢关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700016429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2575410801","title":"股市必读:易明医药(002826)股东户数1.94万户,较上期减少8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575410801","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575410801?lang=zh_cn&edition=full","pubTime":"2025-10-13 04:39","pubTimestamp":1760301549,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,易明医药报收于19.15元,上涨1.0%,换手率2.85%,成交量4.97万手,成交额9530.86万元。交易信息汇总资金流向10月10日主力资金净流出311.55万元;游资资金净流出472.49万元;散户资金净流入784.04万元。股本股东变化股东户数变动近日易明医药披露,截至2025年9月30日公司股东户数为1.94万户,较9月19日减少1824.0户,减幅为8.58%。户均持股数量由上期的8968.0股增加至9810.0股,户均持股市值为18.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0033","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769351738306,"stockEarnings":[{"period":"1week","weight":0.0399},{"period":"1month","weight":0.0549},{"period":"3month","weight":-0.0296},{"period":"6month","weight":-0.1727},{"period":"1year","weight":0.741},{"period":"ytd","weight":0.0348}],"compareEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.0495},{"period":"3month","weight":0.047},{"period":"6month","weight":0.151},{"period":"1year","weight":0.2805},{"period":"ytd","weight":0.0422}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18392人(较上一季度减少1.48%)","perCapita":"9478股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":" 西藏易明西雅医药科技股份有限公司的主营业务是糖尿病、心血管疾病等老年慢性病症治疗及妇科领域核心产品的开发和研究。公司的主要产品是米格列醇片、醋氯芬酸肠溶片、蒙脱石散、红金消结片、多潘立酮片、阿奇霉素胶囊、氯雷他定片、注射用多种维生素(12)、多种微量元素注射液。截至报告期末,公司拥有发明专利28件,实用新型专利22件,药品注册批件32件,注册商标83件。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}